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Impact of macular pigment on 
visual performance
 E
vidence is accumulating to 
suggest that macular pigment 
(MP), composed of the dietary 
carotenoids lutein (L), zeaxan-
thin (Z) and meso-zeaxanthin 
(MZ), may have a protective role against 
macular degeneration. But does it also 
have a role in the visual performance of 
normal retinas? At the outset it should be 
stated that current evidence on the poten-
tial of MP to enhance, or at least affect, 
the quality of our visual experience is 
sparse, somewhat mixed and ultimately 
deficient. It has long been known that 
MP absorbs short wavelength (blue) 
light prior to photoreceptor stimulation. 
The theory that filtering such defocused 
blue light could enhance visual acuity 
(and/or contrast sensitivity) by reduc-
ing the effects of chromatic aberration 
goes back as far as Schültze in 1866. 
This hypothesis, specifically in relation 
to MP, has, however, remained largely 
unexplored and unproven. 
The selective accumulation of only 
three specific dietary carotenoids, to the 
exclusion of the other 40 dietary carote-
noids, suggests an exquisite biological 
selectivity for L, Z and MZ at the site of 
maximum visual acuity in the human 
retina, and indicates a role for these 
carotenoids which is uniquely suited 
to this anatomic location. Given that 
Darwinian natural selection is driven 
by phenotypic expression of genetic 
background – which confers advantage 
before and until the period of procrea-
tion – it follows that the biological 
selectivity of MP’s accumulation in the 
retina primarily represents an advantage 
in young and middle age. An alternative 
to the visual performance hypothesis is 
that MP protects the retina against blue 
light damage, but since ARM and AMD 
are age-related conditions, it is doubtful 
that this degree of biological selectivity 
evolved to protect against such condi-
tions. In other words, it is possible that the 
primary role of MP involves its contribu-
tion to visual performance.
MP most certainly affects visual 
experience by altering the spectral 
composition of the light incident upon 
macular photoreceptors. Whether such 
short wavelength absorption influences 
the quality of the visual experience, 
and whether the magnitude of such 
an effect correlates with MP optical 
density are larger questions that remain 
largely unaddressed, and definitely 
unanswered.
To address the question of whether 
MP may influence visual perform-
ance, one must (a) initially consider the 
primary factors that affect performance, 
(b) outline the properties of MP that 
make it potentially useful in enhanc-
ing visual performance in light of any 
such limiting factors, (c) analyse exist-
ing evidence in favour and/or against a 
putative role for MP in visual perform-
ance enhancement and (d) design experi-
mental strategies that might more clearly 
elucidate the answers to the question of 
whether MP has a role to play.
Visual performance
Vision includes the capacity to detect 
objects against a contrasting background, 
to detect gaps between objects (such as 
in vernier tasks which provides one 
example of a hyperacuity), to recognise 
and identify objects, to perceive colour, to 
detect movement and to perceive depth 
among others. The capacity to recognise 
a small letter from a distance bears little 
relation to the capacity to differentiate 
colours or to detect a potential threat such 
as an oncoming vehicle in the peripheral 
field of view. Performance is critically 
dependent on illumination. The range of 
illumination we experience in the course 
of a day is vast. The visual system copes 
with the huge range of luminances by 
adapting to the prevailing conditions 
and can function through a staggering 
luminance range of nearly 10 log units. 
Although adaptation facilitates perform-
ance over a wide range of ambient illumi-
nation levels, this does not mean that we 
see equally well at all levels. Under dim 
conditions the eyes are very sensitive and 
can detect subtle changes in luminance 
but acuity for pattern details and colour 
discrimination are poor.  
Shaler (1937) has explored the relation-
ship between illumination and grating 
acuity. Converting his findings to Snellen 
equivalent, daylight (photopic) perform-
ance of 6/3 reduces to 6/90 under 
dim conditions, a 30-fold reduction. 
Threshold visibility, colour appearance 
and visual acuity all vary dramatically at 
different illumination levels, and these 
visual parameters change over the time-
course of light and dark adaptation. No 
single test or testing condition can there-
fore define visual performance. 
It is also important to remember that 
when describing visual processes, vision 
also involves the processes leading to 
perception. The visual system employs 
numerous anatomical and physiological 
strategies including lateral interactions 
between cells, specific receptive field 
organisation, spatial retinotopic organi-
sation in retinal and non-retinal areas 
of the pathway, colour opponency and 
parallel visual pathways among others 
in order to achieve an instantaneous 
(stable and constant), yet coherent and 
highly detailed perception of the outside 
world and our position within it. Such 
image processing is not exclusive to 
the brain but extends throughout the 
visual pathway beginning at the retina. 
The eyes and brain are thus inextrica-
bly linked with the visual universe. The 
eyes actively record the form, colour 
and movements of the world, and the 
brain moulds these raw perceptions 
into recognisable patterns. The retina 
essentially acts as a spatial, temporal and 
spectral filter of patterns of light striking 
its surface. Its anatomical structure and 
the functional properties of individual 
cells determines the type of informa-
tion extracted from a visual scene and 
delivered to the brain, namely the retina 
analyses and controls what information 
is delivered to the brain. 
Specialisation of the macula
The macula, which comprises less than 4 
per cent of the total retinal area, accounts 
for almost all of our useful photopic 
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vision. Several distinctive anatomical and 
neural adaptations facilitate such high 
level visual performance. These include: 
● Cone density reaches a peak at the 
centre of the macula (fovea) which 
intersects the line of sight. Cone density 
exceeds rod density only at the lower part 
of the foveal slope reaching a maximum 
at the base of the fovea (foveola) where 
cone density is more than three times the 
density at the base of the foveal slope 
(Curcio et al, 1990). Rods, ganglion cells 
and all inner nuclear layer neurons are 
absent from the foveola so that only here 
is light directly incident on photorecep-
tors (elsewhere light must traverse the 
various retinal cells and layers to reach 
photoreceptors).
● Midget pathways arising from these 
foveal cones dominate. Such parvocellu-
lar midget pathways are tuned to high 
spatial frequencies (allowing high acuity) 
and also exhibit colour opponency.
● Such midget pathways are distinc-
tive in the absence of convergence 
of photoreceptor signals onto bipolar 
and ganglion cells. Absent or reduced 
convergence of information preserves 
the information gathered at the fovea for 
delivery to the visual cortex. This differ-
ence between foveal and extra-foveal 
processing generates a hierarchy in the 
importance of retinal information.
● The retinal hierarchy afforded to foveal 
cone-mediated vision extends back to the 
visual cortex where the central retinal 
pathways have by far the greatest repre-
sentation (Wong and Sharpe, 1999; 
Horton and Hoyt, 1991).
Having outlined those anatomical 
and neural factors central to primates’ 
capacity for high acuity vision, it is now 
important to consider the potential role 
of macular pigment in further enhanc-
ing visual performance. In order to do so, 
it is essential to characterise (a) the optical 
limitations that might restrict visual 
performance (in particular chromatic 
aberration and light scatter) and (b) 
the properties of macular pigment 
that might serve to lessen the effect of 
such limitations and thereby facilitate 
improved performance.
Optical limitations of the eye
Monochromatic aberrations and diffrac-
tion limit the image quality produced by 
the eye so that the image is not a high 
quality representation of the object. 
While there is significant ocular and 
neural correction for and adaptation to 
such image defects, macular pigment has 
no role in altering their effects.
Chromatic aberration
Chromatic aberration, comprising both 
longitudinal (LCA) and transverse 
(TCA) components, has been cited as 
possibly the most significant aberra-
tion affecting visual quality (Howarth 
and Bradley, 1986). LCA creates up to 
two dioptres of wavelength-dependent 
optical defocus (Figure 1). 
 The effect of LCA across wavelength 
in terms of blur is non-linear – that is 
shorter wavelengths are significantly 
more blurred than longer wavelengths. 
For example, for a typical eye focused 
at 555nm, light at 460nm suffers 1.2D 
myopic defocus, while the equivalent 
long wavelength of 650nm is only 
0.50D out of focus (Howarth and 
Bradley, 1986). This serves to create 
a purple blur circle haze around the 
focussed ‘green’ component. The ultimate 
effect of such optical aberrations, and in 
particular LCA, is that capacity limits are 
somewhat reduced so that the anatomi-
cal limits of acuity based on foveal cone 
diameter (30 secs arc – equivalent to 6/3), 
are seldom achieved even by healthy 
normal individuals. 
Light scatter
If one looks up to the sky on a bright, 
cloudless sunny day, one could be 
fooled into thinking that the sun’s rays 
traverse an unobstructed path to the eye. 
Furthermore, one could certainly not 
imagine the quality of the light visible 
was being degraded as it traversed the 
seemingly clear sky, even in the most 
remote countryside locations far from 
the smog-filled cityscapes on its way to 
the eye. The fact that the sky is blue is 
testament to the impact of the process 
of light scatter, whereby, particle matter 
including haze aerosols, fog, and cloud 
abstracts and re-radiates energy from 
light incident upon it.
Wooten and Hammond (2002), in an 
excellent review of the importance of 
light scatter to the ‘visibility’ of objects, 
eloquently describe why light scatter, 
especially that induced by haze aerosols 
‘critically determines how far one can see 
and how well details can be resolved’, so 
that, aside from the optical and neural 
limits, ‘scatter in the haze aerosols is the 
primary determinant of visual discrimi-
nation and range in the outdoors’.
The question therefore arises, what 
effect does light scatter have on visual 
performance? It is a good question. On a 
clear day one can see for miles despite the 
effects of scatter. However, it has been 
shown that compensation for the effects 
of light scatter, such as could reasonably 
be achieved by increasing the density 
of macular pigment could increase 
the visibility and discriminability of 
targets in natural settings (Wooten and 
Hammond, 2002). Tackling the question 
from another perspective, the problems 
caused by scatter, while not consciously 
experienced by some people, do become 
a significant symptom of which many of 
our patients complain. Typical examples 
include those with light-coloured irides, 
cataract, corneal abnormalities and infec-
tions, and post-laser refractive patients 
among others. Scatter, therefore, does 
have an adverse effect on the visual 
experience of normals and those with 
ocular abnormalities alike, and there-
fore any means to reduce the effects of 
scatter can only be of benefit. So now the 
question arises, what are the properties 
of MP that might allow it to improve 
visual performance in light of the limit-
ing factors outlined above?
Optical properties of MP
The ‘optical’ hypotheses of MP were 
discussed in significant detail initially 
by Reading and Weale (1974), and later 
by Nussbaum et al (1981), and may be 
related to at least one of the following 
properties: MP may enhance visual 
acuity by reducing chromatic aberra-
tion; MP may reduce visual discomfort 
by attenuation of glare and dazzle; MP 
may facilitate enhancement of detail by 
the absorption of ‘blue haze’; MP may 
enhance visual contrast.
MP has the capacity to achieve the 
above optical effects because of its optical 
properties and its location in the retina.
The term macula is actually derived 
from the presence of the xanthophyll 
pigments, lutein (L) and zeaxanthin (Z), 
at the central region of the retina, which 
give rise to the appearance of a yellow 
spot ‘macula lutea’ when viewed under 
red-free light. The yellow nature of MP 
is such that it selectively absorbs blue-
green incident light, with maximum 
absorption circa 460nm and little or no 
absorption above 530nm (Bone et al, 
1992). Given that, (a) the peak retinal 
spectral sensitivity lies at 555nm, (b) the 
percentage of blue (short wavelength 
sensitive) cones compared to that of 
Figure 1 Longitudinal chromatic aberration – focal length for 
incident white light varies across wavelengths
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red (long wavelength sensitive) and 
green (medium wavelength sensitive) 
cones is vastly reduced and (c) there is 
a complete absence of blue cones from 
the region of maximal visual perform-
ance, the foveola, MP it seems therefore 
removes that component of light which 
has least benefit from a performance 
perspective. 
Two aspects of MP location within the 
retina are also central to the assumption 
that it has a role to play in visual perform-
ance. Firstly, although MP is diffusely 
distributed throughout the retina and 
other ocular structures (Davies and 
Morland, 2004), it is mostly concentrated 
at the macula and remains optically 
undetectable elsewhere. Secondly, and 
importantly, MP is located at a pre-recep-
torial level, so such absorptions are made 
prior to light stimulation of underlying 
photoreceptors, thereby altering the 
spectral distribution of light incident on 
such photoreceptors. 
Given its short wavelength absorption 
characteristics and central, pre-receptorial 
location, MP retains ideal properties to 
improve visual performance. Blue light 
absorption attenuates the more disadvan-
tageous short wavelength component 
of LCA. Retinal image quality is, there-
fore, improved and visual performance 
across the full contrast range is theoreti-
cally more refined. As MP absorption 
overlaps with that of rhodopsin, MP 
may reduce rod signal effectiveness in 
the mesopic range, and thus extend the 
usefulness of cone-mediated vision into 
the mesopic range (Kvansakul et al, 2006). 
In addition, blue light absorption has the 
benefit of improving target contrast by 
selectively reducing the scattered blue 
light in the background. Reduced LCA 
and reduced scatter effects associated 
with MP therefore have the combined 
potential to improve visual acuity and 
target visibility (Wooten and Hammond, 
2002). 
The higher energy and retinal irradi-
ance associated with shorter wavelengths 
also merits consideration. Bright light, 
which interferes with the quality of 
visual perception is termed glare, of 
which there are numerous types. Glare 
is a frequent complaint among persons 
with advanced age, retinal disease, and 
cataract, as well as at any age in some 
individuals without obvious reasons 
for predisposition. In high luminance 
or high contrast situations, where glare 
and dazzle are maximal, MP absorp-
tion of blue light removes the highest 
energy light component, reduces retinal 
irradiance and may therefore have the 
combined benefits of minimising the 
impact of glare on performance and 
increasing the threshold for photopho-
bia under normal viewing conditions. 
Because of their linear structure, L and 
Z also exhibit dichroic properties, which 
facilitate glare reduction by preferential 
absorption of polarised light. The extent 
of glare reduction by preferential absorp-
tion of polarised light has not yet been 
quantified however.
It should hopefully now be clear, 
because visual performance is a highly 
complex issue, difficult to quantify, and 
dependent on numerous independ-
ent and overlapping variables, that to 
quantify the role of any one factor such 
as MP optical density (MPOD) presents 
numerous difficulties. It is with this 
thought in mind that the currently avail-
able evidence on the visual performance 
effects of MP will now be explored.
Experimental studies
As stated at the outset, the evidence 
in relation to a role for MP in visual 
performance is sparse and in fact is 
mainly associative. In terms of visual 
acuity and contrast sensitivity there are 
no published studies of which we are 
aware that conclusively address this 
hypothesis. Instead there are numerous 
conflicting investigations of the effect 
of yellow filters on visual perform-
ance (Wolffsohn et al, 2000). None of 
these studies, however, have measured 
MPOD. Failure to do so clouds any 
reasonable interpretation of the perform-
ance effects of blue light absorption as 
variations in MP density between and 
within study populations could fully 
account for conflicting results. Those 
with high MPOD would logically attain 
least benefit and those with low MPOD 
gain most. 
Those studies that have addressed visual 
performance are largely confined to 
populations with established eye disease. 
As such the results, although important, 
must be analysed in full knowledge that 
their implications may not necessarily 
fully translate into a normal population. 
Studies involving normal subjects will 
be analysed separately.
Eye disease studies
(1) Congenital retinal degenerations
Abnormal light sensitivity, associated 
difficulty with glare, loss of contrast 
and slow dark adaptation are common 
symptoms of congenital and acquired 
retinal degenerations. It has been 
suggested that such symptoms could 
be partially attributed to the failure of 
MP to absorb the scattered light, result-
ing in reduced contrast and definition 
along with excessive photoreceptor 
pigment bleaching by short wavelength 
light components. The antioxidant and 
protective properties of MP makes it a 
prime candidate for use in retinal degen-
erations where long-term macular vision 
preservation has such important lifestyle 
implications. It is notable that there have 
been reports (some dating back more 
than 50 years) suggesting visual benefit 
in retinitis pigmentosa from lutein-
containing medicaments (reviewed by 
Nussbaum, 1981). 
Aleman et al (2007) analysed patients 
with Stargardt’s disease or cone-rod 
dystrophy and known or suspected 
disease-causing mutations in the ABCA4 
gene to determine baseline MPOD and 
also response to L supplementation in 
terms of MPOD changes and central 
visual function changes. They reported 
that MPOD is strongly affected by the 
stage of ABCA4 disease leading to 
abnormal foveal architecture. MP could 
be augmented by supplemental lutein in 
about two-thirds of patients. However, 
visual function measures, including 
visual acuity and foveal sensitivity, 
showed no discernable improvement 
after six months of lutein supplemen-
tation. They conclude that long-term 
influences of L supplementation on the 
natural history of these macular degen-
erations require further study.
Dagnelie et al (2000), in a primitively 
designed study, assessed the effect of L 
supplementation in patients with retini-
tis pigmentosa (RP). They reported 
moderate vision improvements in RP 
patients in response to short-term L 
supplementation. Mean visual acuity 
improved by 0.7dB and mean visual-
field area by 0.35dB, although the largest 
gains were attained by blue-eyed partici-
pants. Aleman et al (2001) explored the 
relationship between visual function and 
L supplementation in RP patients over 
a six-month period and despite signifi-
cant increases in MPOD, could find no 
significant improvement in perform-
ance (measured as absolute foveal sensi-
tivity). The dosage used in this study 
was lower than that in the Dagnelie 
report which may be of importance. 
Neither study, however, analysed visual 
function in sufficient detail to determine 
whether the natural history is altered by 
supplementation.
Duncan et al (2002) analysed MP 
levels and macular function in choroi-
deraemia (a progressive degeneration of 
photoreceptors, RPE and choroid). Once 
again, despite increased MPOD after 
supplementation, no improvement in 
retinal sensitivity was seen. 
(2) Age-related macular 
degeneration
AMD, as the leading cause of blind-
ness in the western world, has been the 
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primary research focus for the effects of 
L and Z supplementation. Observations 
including relative preservation of blue 
cones centrally compared to perifoveally 
(Shaban et al, 2002) and geographic 
atrophy in AMD typically appearing 
initially in the perifovea where MP 
density is lowest, lend weight to the asser-
tion that MP protects visual function at 
the fovea. Since the original findings 
of the Eye Disease Case-Control Study 
Group of a 60 per cent reduced risk of 
developing AMD associated with high 
intakes of L and Z (Seddon et al, 1994), 
numerous investigators have explored 
the relationship between L and Z in the 
diet or blood and AMD. With a couple of 
exceptions (outlined below), empirical 
studies on the effects of L and Z supple-
mentation on AMD progression, in terms 
of visual function, focus mainly (and 
understandably) on the capacity of L and 
Z supplementation to halt progression of 
functional loss, not on the potential to 
improve visual function in established 
AMD. Results have been somewhat 
variable, with some studies showing a 
beneficial effect of higher intakes of L 
or Z (Mares-Periman et al, 2001; Snellen 
et al, 2002; Gale et al, 2003), while others 
have not (VandenLangenberg et al, 1998; 
Flood et al, 2002; Cho et al, 2004). 
Falsini et al (2003) measured the effect 
of L supplementation on central electro-
physiological function in patients with 
AMD and found a significant increase 
in focal ERG amplitude after six months’ 
supplementation, followed by decreased 
amplitude back to baseline follow-
ing cessation. Curiously, they did not 
record MPOD so their conclusions are 
somewhat limited. The lutein antioxidant 
supplementation trial study provides the 
most intriguing findings in relation to 
visual function among AMD patients. 
Patients supplemented with L or L plus 
other antioxidants achieved improved 
visual function outcomes attributable 
to increased MPOD measures. Snellen-
equivalent acuity improved by 5.4 letters 
in the L group and by 3.5 letters in the 
L plus antioxidant group (Richer et al, 
2004). Improvements were also seen in 
contrast sensitivity and subjectively on 
Amsler grid and glare recovery. Placebo 
control subjects achieved no such 
improvements. 
(3) Other conditions
Olmedilla et al (2003) explored the possi-
bility that L supplementation might 
influence visual function in patients with 
age-related cataract. Visual performance 
was evaluated through visual acuity 
and glare sensitivity measures. This 
randomised, placebo-controlled study 
revealed significant improvements in 
visual acuity and glare sensitivity associ-
ated with increased blood serum L 
levels after supplementation. No such 
improvements were achieved in placebo 
controls or in those supplemented with 
a-tocopherol. The authors postulate that 
such improvements are not the conse-
quence of any change in the crystalline 
lens, but from possibly improved retinal 
integrity.
Cystic fibrosis (CF) is a condition 
associated with deficient carotenoid 
absorption due to pancreatic insufficiency. 
Carotenoid concentrations, including the 
MP components, are almost uniformly 
low in CF patients. Beatty et al (2004) 
have shown that ocular MP levels vary 
with blood serum levels and therefore 
MP levels can be assumed to be low in 
cases of CF. Schupp et al (2004) assessed 
visual performance in 10 such CF 
patients. Serum L and Z concentrations, 
as well as MPOD in the eye were signifi-
cantly reduced in CF patients to less 
than half the levels of control subjects. 
Visual performance on contrast sensitiv-
ity, colour discrimination and multifocal 
ERG amplitudes, although better in the 
control group, were, however, not statis-
tically significantly different between 
the two groups.
Normal population studies
(1) Photophobia and glare
Photophobia is a global phenom-
enon experienced under sudden and 
extreme changes of illumination from 
dark to light, for example turning on 
the bedroom lights at night. However, 
under normal daylight conditions, the 
experience of photophobia is somewhat 
more variable. Numerous clinical condi-
tions cause photophobia, and even in 
the absence of detectable disease, clini-
cians are often presented with patients 
whose primary complaint is of periodic 
or persistent hyper-sensitivity to bright 
light. Given its absorption characteristics, 
MP, and in particular the density of MP 
may have a central role in determining 
the individual photophobia threshold. 
Stringham et al (2003) explored the 
effect of the spectral composition of 
a target on visual discomfort. They 
showed that while there was a positive 
relationship between wavelength and 
the energy needed to produce photopho-
bia for wavelengths between 520nm and 
640nm, at shorter wavelengths there was 
a notch centred at 460nm. MPOD differ-
ences among the subjects also appeared 
to account for differences in photopho-
bic sensitivity below 520nm. 
Such findings led to a subsequent study 
to test the direct relationship between MP 
and photophobia (Wenzel et al, 2006). 
This two-part experiment explored the 
relationship between baseline MPOD 
levels and photophobia thresholds, as 
well as the effect of increasing MPOD 
on such thresholds. They found a linear 
relationship between baseline MPOD 
and photophobia – that is individuals 
with higher MPOD were less suscepti-
ble to photophobia. 
Furthermore, increasing MPOD over 
a 12-week period appeared to confer a 
predictable improvement in photopho-
bia threshold increasing the amount of 
light necessary to induce visual discom-
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1 What percentage of the total retinal area is the macula?
A 1 per cent
B 4 per cent
c 10 per cent
D 15 per cent
2 Relating to longitudinal chromatic aberration, which of the following is true?
A The typical eye focused light at 460nm
B  Light of 460nm will be less blurred than that 
of 650nm
C  Shorter wavelengths are significantly more 
blurred than longer wavelengths
D  Chromatic aberration has no influence on the 
limt of acuity
3 What is the maximum absorption wavelength of macular pigment?
A 460nm
B 555nm
C 560nm
D 650nm
4 Which of the following is true regarding Stargardt’s disease?
A MPOD is not affected
B  Macular pigment was unaffected by 
supplementation
C There is no genetic component to the disease
D  No visual function improvement is noted after 
six months of supplementation
5 Which of the following is true regarding retinitis pigmentosa?
A  Moderate vision improvements have 
been reported with short-term lutein 
supplementation
B  Best improvements are in dark iris patients
C  Lower dose supplementation has shown 
benefits in visual function
D  Mean acuity increases of 0.35 dB have been 
reported
6 Which of the following is true regarding cystic fibrosis?
A  It is associated with excess carotenoid levels
B  Blood serum levels of macular pigment are 
elevated
C  Studies have shown little change in 
visual function with macular pigment 
supplementation
D  Carotenoid level irregularity is associated with 
duodenal insufficiency
fort for short wavelength targets.
Recent data from Hammond et al 
– presented at ‘Coloured filters in the 
Eye’ at City University in November 
last year – found that both photostress 
recovery and grating visibility under 
veiling conditions were strongly related 
to MP density, supporting the photopho-
bia findings outlined above.
(2) Acuity and contrast sensitivity
Engles et al (2007) have evaluated 
the ‘acuity hypothesis’, exploring the 
relationship between gap acuity, vernier 
acuity and MPOD under photopic 
conditions. They report that neither gap 
acuity nor vernier acuity were signifi-
cantly correlated with MPOD and 
conclude that their ‘data suggest that 
the predictions of the acuity hypoth-
esis do not hold’. Numerous limitations 
(some recognised by the authors) in their 
study design, however, mean that such 
a conclusion goes far beyond the scope 
of their findings and cannot be justi-
fied. The acuity findings, however, do 
suggest that the contribution of MP to 
visual performance may be less impor-
tant for the aspects of photopic vision 
to which the system is most highly 
tuned. Retinal image quality is adversely 
affected in mesopic conditions as a result 
of increased aberrations and scattered 
light. Visual performance is typically 
much more variable in the mesopic 
range, where the influence of rods on 
spatio-temporal vision pre-dominates 
and results in reduced contrast acuity. 
As rods are sensitive to blue light 
(peak rod sensitivity lies around 498nm 
in the blue-green part of the spectrum), 
Kvansakul et al (2006) have postulated 
that blue light absorption may reduce rod 
signals and thereby extend the superior 
characteristics of  cone-dominated 
vision lower into the mesopic range. 
They investigated the effect of increas-
ing MPOD through L and Z supple-
mentation on contrast acuity and found 
that regardless of whether groups were 
supplemented with L, with Z, or with 
a combination of the two, there was 
a trend towards improved perform-
ance. The improvement was statisti-
cally significant for the L group so that 
supplementation has now been shown 
to enhance visual performance at low 
illumination levels.
Conclusion
Visual performance in the normal 
human observer is less than ideal. 
Evidence exists that once chromatic 
and monochromatic aberrations are 
removed, visual performance improves 
(Yoon and Williams, 2002). As such 
numerous strategies exist which aim to 
improve visual performance. 
Wavefront-guided laser refractive 
eye surgery, wavefront-guided spectacle 
lenses, blue-filtering IOL implants, blue-
filtering contact lenses and blue-filtering 
spectacle lenses all attempt to improve 
or optimise visual performance. All 
such techniques, however, are designed 
primarily for persons with pre-existing 
ocular abnormality or disease. 
It is generally accepted and has been 
shown that age results in a decline in 
visual function for a wide variety of 
reasons. MP has been shown to preserve 
visual function in age-related retinal 
disease such as AMD presumably by 
protecting remaining foveal cones. By 
preserving foveal cones and possibly 
crystalline lens clarity MP may thus 
retard functional losses into old age.
To summarise, MP has ideal proper-
ties in terms of location and spectral 
absorbance to have a beneficial effect on 
visual performance. Longer life spans, 
increased exposure to short wavelength 
blue light (ancestors had no blue light 
exposure after dark), increased effects 
of scatter from expanding smog and 
haze, modern visual requirements and 
the explosion in the incidence of AMD 
heightens the importance of both improv-
ing visual performance in the short term, 
and preserving such performance in the 
long term. 
Definitive supporting evidence, 
however, has not been provided with 
sufficient clarity and depth to fully 
describe the role of MP in vision, neither 
in the short term nor over time. 
Interpretation of the findings in the 
studies cited above should therefore 
be approached with full appreciation 
of the design flaws, insufficient visual 
performance evaluation, and in partic-
ular the small sample sizes used. High 
quality emergent research with sufficient 
subject numbers tracked longitudinally 
is now required to address the issue more 
completely. ● 
● J Loughman and PA Davison are 
from the Optometry Department, Dublin 
Institute of Technology and John Nolan 
and Stephen Beattie are based at 
the Macular Pigment Research Group, 
Waterford Institute of Technology
